- IQVIA Holdings Inc IQV has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12
- Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 percent at constant currency, ahead of the consensus of $3.35 billion.
- Technology & Analytics Solutions' revenue of $1.3 billion grew 10.8% on a reported basis and 9.9% at constant currency.
- Research & Development Solutions (R&DS) revenue increased 32.4% on a reported basis and 31.9% at constant currency to $1.8 billion. R&D Solutions contracted backlog of $24.4 billion grew 12.7% Y/Y.
- Adjusted EBITDA increased 20.5% to $728 million.
- Q3 Operating cash flow was $844 million, and free cash flow was $682 million.
- Outlook: IQVIA has raised FY21 sales guidance to $13.77 billion - $13.85 billion, versus ($13.55 billion - $13.70 billion expected earlier), vs. street estimate of $13.68 billion.
- It forecasts adjusted EPS of $8.85 - $8.95, compared to earlier guidance of $8.70 - $8.90, compared to the $8.83 consensus.
- Adjusted EBITDA is expected to be $2.9 billion - $3 billion.
- Price Action: IQV shares traded lower by 4.58% at $240 premarket on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in